Pregled bibliografske jedinice broj: 143511
Molecular effects of lithium on human A1235 glioblastoma cells: is lithium a neuroprotective drug?
Molecular effects of lithium on human A1235 glioblastoma cells: is lithium a neuroprotective drug? // 2. znanstveni simpozij 45 godina molekularne biologije u Hrvatskoj 50 godina dvostruke uzvojnice : knjiga sažetaka / Ambriović Ristov, Andreja ; Brozović, Anamaria (ur.).
Zagreb: Institut Ruđer Bošković, 2003. str. 44-44 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 143511 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Molecular effects of lithium on human A1235 glioblastoma cells: is lithium a neuroprotective drug?
Autori
Karlović, Dalibor ; Jakopec, Sanjica ; Dubravčić, Klara ; Batinić, Drago ; Buljan, Daniel ; Osmak, Maja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
2. znanstveni simpozij 45 godina molekularne biologije u Hrvatskoj 50 godina dvostruke uzvojnice : knjiga sažetaka
/ Ambriović Ristov, Andreja ; Brozović, Anamaria - Zagreb : Institut Ruđer Bošković, 2003, 44-44
Skup
2. znanstveni simpozij 45 godina molekularne biologije u Hrvatskoj 50 godina dvostruke uzvojnice
Mjesto i datum
Zagreb, Hrvatska, 21.11.2003. - 22.11.2003
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
lithium; neuroprotection; survivin; glioblastoma cells
Sažetak
Mood stabilizers represent a class of drugs that are efficacious in the treatment of bipolar disorders. One of the most established medications in this class is lithium. The recent finding suggest that lithium, besides mood stabilization, might be involved in neuroprotection. The aim of present study was to analyze molecular mechanisms induced in human glioblastoma A1235 cell line by the treatment with lithium. Cytotoxicity of lithium was examined by spectrophotometric MTT assay. To determine the distribution of cells in the cell cycle, flow cytometry was used. The expression of antiapoptotic proteins Bcl-2 and survivin was examined by Western blot method. Results show that 72 h incubation with lower levels of lithium (0.5 mM and 2 mM), did not caused any cytotoxicity or changes in the cell-cycle phases-distribution. However, higher dose (20 mM) was cytotoxic for glioblastoma cells, causing disturbance in cell-cycle phases, with the accumulation of cells in G2/M phase of the cell-cycle. During the treatment with lithium, the level of antiapoptotic protein Bcl-2 did not changed, while the level of survivin increased, even with the lower, therapeutic relevant doses of this drug. In conclusion, therapeutic concentrations of lithium are not cytotoxic for human glioblastoma cells. Evemore, they could be involved in neuroprotection due to the induction of expression of antiapoptotic protein
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Projekti:
0098076
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Maja Osmak
(autor)
Drago Batinić
(autor)
Dalibor Karlović
(autor)
Sanjica Rak
(autor)
KLARA DUBRAVČIĆ
(autor)